Zang, X.; Wang, Y.; Han, C.; Cui, L.; Liu, H.; Tian, S.; Liu, K.; Li, P.; Sun, C.; Xia, Q.;
et al. 2-Acetamidophenol (2-AAP) Suppresses the Progression of Atherosclerosis by Alleviating Hyperlipidemia and Attenuating the Ferroptosis Pathway. Mar. Drugs 2024, 22, 513.
https://doi.org/10.3390/md22110513
AMA Style
Zang X, Wang Y, Han C, Cui L, Liu H, Tian S, Liu K, Li P, Sun C, Xia Q,
et al. 2-Acetamidophenol (2-AAP) Suppresses the Progression of Atherosclerosis by Alleviating Hyperlipidemia and Attenuating the Ferroptosis Pathway. Marine Drugs. 2024; 22(11):513.
https://doi.org/10.3390/md22110513
Chicago/Turabian Style
Zang, Xiaohan, Yongcheng Wang, Cong Han, Lishuang Cui, Haojie Liu, Shuimiao Tian, Kechun Liu, Peihai Li, Chen Sun, Qing Xia,
and et al. 2024. "2-Acetamidophenol (2-AAP) Suppresses the Progression of Atherosclerosis by Alleviating Hyperlipidemia and Attenuating the Ferroptosis Pathway" Marine Drugs 22, no. 11: 513.
https://doi.org/10.3390/md22110513
APA Style
Zang, X., Wang, Y., Han, C., Cui, L., Liu, H., Tian, S., Liu, K., Li, P., Sun, C., Xia, Q., & Zhang, Y.
(2024). 2-Acetamidophenol (2-AAP) Suppresses the Progression of Atherosclerosis by Alleviating Hyperlipidemia and Attenuating the Ferroptosis Pathway. Marine Drugs, 22(11), 513.
https://doi.org/10.3390/md22110513